Valuation: 10x Genomics, Inc.

Market Cap 5.97B 5.25B 4.9B 4.5B 8.42B 572B 8.62B 58.1B 22.72B 283B 22.43B 21.94B 979B P/E 2026 *
-58x
P/E 2027 * -67.4x
Enterprise Value 5.49B 4.83B 4.51B 4.14B 7.74B 526B 7.93B 53.44B 20.9B 260B 20.63B 20.18B 900B EV / Sales 2026 *
8.95x
EV / Sales 2027 * 8.08x
Free-Float
90.53%
Yield 2026 *
-
Yield 2027 * -
1 day-1.83%
1 week-1.83%
Current month+20.47%
1 month+24.33%
3 months+128.66%
6 months+122.07%
Current year+183.20%
1 week 45.01
Extreme 45.01
49.5
1 month 35.12
Extreme 35.12
49.5
Current year 15.9
Extreme 15.9
49.5
1 year 11.16
Extreme 11.16
49.5
3 years 6.78
Extreme 6.78
63.57
5 years 6.78
Extreme 6.78
191.15
10 years 6.78
Extreme 6.78
208.99
Manager TitleAgeSince
Chief Executive Officer 49 2012-07-01
President 51 2012-09-30
Director of Finance/CFO 51 2024-08-11
Director TitleAgeSince
Director/Board Member 51 2012-07-01
Director/Board Member 49 2012-07-01
Chairman 68 2013-07-31
Date Insider Type Main position Quantity % Market Cap.
6/22/26 Sell

Founder

-30,000 0.0257%
6/16/26 Sell

Director

-5,723 0.0049%
6/4/26 Free

Director

8,829 0.0076%
Change 5-day change 1-year change 3-year change Capi.($)
+0.29%-1.83%+229.93%-26.66% 5.97B
-3.94%-3.58%+235.55%+272.53% 19.04B
-2.80%+3.48%-41.63%-25.88% 10.07B
+10.22%-4.55%+38.30%+15.45% 6.68B
+0.31%+4.14%-15.57%-20.65% 5.53B
+1.09%+0.91%-43.60% - 4.41B
+0.34%+5.10%-21.46%-30.05% 4.26B
-0.33%-16.23%+70.56%+88.36% 4.15B
+2.54%+0.15%-18.58%-43.19% 2.69B
-0.90%-15.99%-43.15%+171.99% 1.45B
Average -0.46%-1.88%+39.04%+44.66% 6.43B
Weighted average by Cap. -0.45%-1.70%+85.67%+85.71%

Financials

2026 *2027 *
Net sales 614M 540M 504M 462M 865M 58.82B 887M 5.97B 2.34B 29.11B 2.31B 2.26B 101B 671M 590M 551M 505M 946M 64.32B 969M 6.53B 2.55B 31.83B 2.52B 2.47B 110B
Net income -104M -91.79M -85.68M -78.64M -147M -10.01B -151M -1.02B -397M -4.95B -392M -384M -17.12B -90.68M -79.68M -74.38M -68.26M -128M -8.69B -131M -882M -345M -4.3B -340M -333M -14.86B
Net Debt -478M -420M -392M -360M -674M -45.82B -691M -4.65B -1.82B -22.67B -1.8B -1.76B -78.37B -548M -482M -450M -413M -772M -52.49B -791M -5.33B -2.08B -25.98B -2.06B -2.01B -89.8B
Logo 10x Genomics, Inc.
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
Employees
1,178
Date Price Change Volume
26-07-29 US$46.33 -1.53% 1,867,083
26-07-28 US$47.05 +2.46% 2,572,644
26-07-27 US$45.92 -0.76% 2,109,133
26-07-24 US$46.27 -3.72% 2,671,917
26-07-23 US$48.06 +2.15% 2,985,305
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
47.05USD
Average target price
41.54USD
Spread / Average Target
-11.71%

Quarterly revenue - Rate of surprise